Baxter’s Tisseel fibrin sealant Firm gains expanded FDA approval via biologic license application supplement to market its Tisseel fibrin sealant for general hemostasis in surgery when control of bl
Hoping to succeed in the elusive field of AF, Endosense is taking an anti-start-up strategy: focusing more on later-stage commercialization and market launch and less on technology vetting. By David C
The News in Medical Devices: Man Doesn't Bite Dog The medical device industry, for the most part, doesn't make news. Here's an experiment you can try at home: scan, in any given month over the past ye
St. Jude Medical Inc. 's recent announcement that it will acquire Endocardial Solutions Inc. (ESI) represents the latest step in St. Jude's aggressive strategy to become a dominant player in the